Genetic variants in SLC39A8 have previously been associated to several cardiovascular risk factors such as HDL-cholesterol [34], [35], blood pressure [36], [37], obesity [38], and activation of plasminogen [39]. This evidence concerns the gene PLG and obesity disorder.